Showing results (741-750 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|February 25, 2011
Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the futurePeter FerenciExpert Opinion on Drug Safety|February 15, 2011
10th annual meeting of the Safety Pharmacology Society: an overviewIcilio CaveroExpert Opinion on Drug Safety|December 23, 2010
Capecitabine and hand-foot syndromeMuhammad Wasif SaifExpert Opinion on Drug Safety|January 20, 2011
Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetesNicholas Avitabile, Ajaz Banka, Vivian A FonsecaExpert Opinion on Drug Safety|January 21, 2011
Safety of perioperative β-blocker use: how do β-blockers compare in terms of side effects?Niels J C Ravensbergen, Michiel T Voute, Don PoldermansExpert Opinion on Drug Safety|June 24, 2010
Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individualsEmil Loldrup Fosbøl, Lars Køber, Christian Torp-Pedersen, et al.Expert Opinion on Drug Safety|June 18, 2010
Introduction of higher doses of deferasirox: better efficacy but not effective iron removal from the heart and increased risks of serious toxicitiesGeorge J KontoghiorghesExpert Opinion on Drug Safety|July 16, 2010
Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplantAhmed F Hawwa, James C McElnayExpert Opinion on Drug Safety|July 22, 2010
Diazepam effects on non-syndromic cleft lip with or without palate: epidemiological studies, clinical findings, genes and extracellular matrixLorella Marinucci, Stefania Balloni, Francesco Carinci, et al.Expert Opinion on Drug Safety|August 13, 2010
Everolimus: efficacy and safety in cardiac transplantationS Allan Schaffer, Heather J RossPageof 282